CYBL Stock DD Cyberlux Corp. 07/31/2014 06:13:04

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
CYBL Cyberlux Corp. $CYBL Company Overview

Stock Message Board http://investorshangout.com/search?q=CYBL&...mp;yt1=Go!

Last Updated: 07/31/2014 06:12:59

Current Price and Quotes
Last Price 0.00
Previous Close N/A Open 0.0001
Daily Range N/A - 0.0001 52wk Range 0.0001 - 0.0004
Volume 5,040,000 Dividend N/A
Average Vol (3m) 60,396,177 Yield N/A




Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 2,695 4,333 3,028 2,273
Cost of Revenue 1,902 2,671 1,650 1,230
Gross Profit 793 1,662 1,378 1,043
Operating Expenses

Research and Development - 1 28 51
Sales, General and Admin. 1,065 1,253 2,004 2,202
Non-Recurring Items - - - -
Other 2 3 12 14
Operating Income (274) 404 (666) (1,225)
Income From Continuing Operations

Add'l Income/Expense Items - 1 3 10
Earnings Before Interest and Tax (273) 405 (663) (1,215)
Interest Expense 224 267 183 243
Earnings Before Tax (497) 138 (846) (1,457)
Income Tax 3 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (499) 138 (846) (1,458)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (499) 138 (846) (1,458)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (499) 138 (846) (1,458)

Recent News

CYBL Cyberlux Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CYBL&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CYBL/quote
Stock Chart http://www.otcmarkets.com/stock/CYBL/chart
Company Info http://www.otcmarkets.com/stock/CYBL/company-info
Recent News http://www.otcmarkets.com/stock/CYBL/news
Financials http://www.otcmarkets.com/stock/CYBL/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CYBL/filings
Short Sales http://www.otcmarkets.com/stock/CYBL/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CYBL/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CYBL/research
Summary http://finance.yahoo.com/q?s=CYBL
Historical Prices http://finance.yahoo.com/q/hp?s=CYBL+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CYBL
Basic Chart http://finance.yahoo.com/q/bc?s=CYBL+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CYBL+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CYBL+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CYBL+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CYBL+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CYBL+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CYBL+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CYBL+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CYBL+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CYBL+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CYBL
Balance Sheet http://finance.yahoo.com/q/bs?s=CYBL
Cash Flow http://finance.yahoo.com/q/cf?s=CYBL+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CYBL
Market Watch http://www.marketwatch.com/investing/stock/CYBL
Bloomberg http://www.bloomberg.com/quote/CYBL:US
Morningstar http://quotes.morningstar.com/stock/s?t=CYBL
Bussinessweek http://investing.businessweek.com/research/st...icker=CYBL
Barchart http://www.barchart.com/quotes/stocks/CYBL
OTC Short Report http://otcshortreport.com/index.php?index=CYBL
Investopedia http://www.investopedia.com/markets/stocks/CYBL/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

TSA PreCheck Study Reveals Time Savings and Travel Insights

Updated Category News Views 379

Understanding TSA PreCheck's Impact on Travelers The latest survey reveals some interesting insights about TSA PreCheck, especially concerning the time savings that members experience at security checkpoints. Conducted by Upgraded Points, this enlightening study assessed the experience of over 1,500 travelers to evaluate the true advantages of holding a TSA PreCheck...

Continue Reading
Intermap Technologies Enhances Geospatial Solutions with New Offering

Updated Category News Views 217

Intermap Technologies Announces New Prospectus Supplement DENVER – Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF), a recognized leader in 3D geospatial products and intelligence solutions, has filed a prospectus supplement in the context of a strategically planned public offering. This initiative signifies a promising step forward, with the company aiming to...

Continue Reading
Urgent Investor Notice: Humacyte Legal Claims Investigation

Updated Category News Views 94

Critical Deadline for Humacyte Investors Approaches As time runs short, investors in Humacyte, Inc. (NASDAQ: HUMA) should pay attention. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors who have suffered losses exceeding $75,000 due to potential violations in federal securities laws. Understanding Your...

Continue Reading
Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab

Updated Category News Views 226

Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab Natalie Bartholomew, a highly recognized advocate for women in financial services, will be the featured speaker for the Women in Banking session at Alkami Co:lab 2026. Her expertise and passion are expected to inspire attendees and foster discussions around women's roles in the financial sector. Alkami...

Continue Reading
Investors Anticipate Strong Earnings from OPAL Fuels Soon

Updated Category News Views 161

OPAL Fuels Earnings Report Insights OPAL Fuels OPAL is preparing to release its quarterly earnings report soon, and investors are keenly interested in the results. As the anticipated date for this report approaches, it is essential for investors to stay informed and understand what the expectations are. Projected Earnings Overview Analysts project that OPAL Fuels will...

Continue Reading